Vaccine Storage And Packaging Market To Reach USD 43.3 Billion By 2030



 Vaccine Storage And Packaging Market Growth & Trends

The global vaccine storage and packaging market size is expected to reach USD 43.3 billion by 2027, expanding at a CAGR of 10.0%, according to a new report by Grand View Research, Inc. Technological advancement in the storage and packaging for medicines, rising government support for research activities and clinical trials, and the growing prevalence of infectious disease are anticipated to drive the market over the forecast period. In addition, increasing government focus on immunization programs, increasing R&D expenditure in biotechnological industries for medical research, and the rising number of pharma retailers are expected to boost the growth of the market. For instance, there are only about 40.0% wards in Nigeria that are equipped with active cold chain equipment. The government of Nigeria is installing at least one functional cold chain equipment in each ward in collaboration with UNICEF, WHO, and CHAI.

Furthermore, most of the biopharmaceutical companies and healthcare institutions are increasingly investing in the development of vaccines. This, in turn, is expected to drive the market over the forecast period. For instance, Innovate UK announced about £66.0 million investment to build and establish a U.K. National Vaccines Manufacturing Innovation Centre in 2018. However, factors such as the availability of refurbished products and stringent regulations are expected to restrain the growth of the market over the forecast period.

Moreover, the COVID-19 outbreak is expected to increase the demand for efficient storage and packaging equipment in the healthcare industry. Most of the global pharmaceutical and biopharmaceutical companies are researching to find a potential vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. The National Institutes of Health (NIH) has partnered with more than 18 biopharmaceutical companies for the development of vaccines against SARS-CoV-2. With the need for global distribution of the approved medicine, high pressure is expected to be built on the cold-chain logistics industry, thus showcasing an opportunity of collaborative efforts among players, leading to industry growth.

In addition, rising awareness about early disease diagnosis and prevention and increasing incidence of infectious diseases has stimulated demand for protective medicines, hence further driving the market. Several efforts undertaken by healthcare organizations such as UNICEF have increased the adoption of protective medicines over the years. UNICEF supply division and Pan American Health Organization (PAHO) revolving fund allow the procurement of medicines at lower prices for various countries. Annually, UNICEF and PAHO procure vaccines for more than 100 countries, which, in turn, is impacting the adoption rate. Thus, capturing market share by means of public contracts is a routine activity of this industry and provides a sustained revenue flow for companies working with government agencies.

An increase in the implementation of the vaccination program by the different governments is one of the major drivers for the market. Increasing vaccination programs have initiated the utilization of public hospitals, clinics, and vaccination centers that has escalated the demand for efficient storage units for the medicines.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/vaccine-storage-packaging-market

Vaccine Storage & Packaging Market Report Highlights

  • By function, the storage segment held the largest market share in 2019 owing to the high cost involved in maintaining the potency of vaccines
  • The storage services segment held the largest market share of over 90.0% in 2019 owing to the increasing demand for vaccine storage services in the industry
  • The packaging segment by the material is sub-segmented into vaccine bags, vials, and ampoules, corrugated boxes, and others. The vaccine bags, vials, and ampoules segment held the largest segment in 2019
  • The packaging segment by packaging level is sub-segmented into the primary, secondary, and tertiary segments. The primary segment held the largest revenue share in 2019 owing to the higher cost of the primary packaging in the industry
  • Europe is anticipated to dominate the market over the forecast period owing to the increasing investments by government and non-government organizations for vaccine development and the high prevalence of infectious diseases within the region.

Vaccine Storage & Packaging Market Segmentation

Grand View Research has segmented the global vaccine storage and packaging market based on function and region:

Vaccine Storage & Packaging Function Outlook (Revenue, USD Million, 2016 - 2027)

  • Storage
    • Storage equipment
      • Refrigerator
      • Freezer
      • Others
    • Service
      • Warehouse storage
      • Transportation
  • Packaging
    • By Packaging Material
      • Vaccine bags, vials, ampoules
      • Corrugated boxes
      • Others
    • By Packaging Level
      • Primary
      • Secondary
      • Tertiary

Vaccine Storage & Packaging Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

List of Key Players of Vaccine Storage & Packaging Market

  • Lineage Logistics
  • AmerisourceBergen
  • DHL
  • DB Schenker
  • Cardinal Logistics
  • McKesson
  • Thermo Fischer Scientific
  • PANASONIC HEALTHCARE CO., LTD
  • American Biotech Supply
  • Arctiko A/S
  • NIPRO
Browse Full Report: https://www.grandviewresearch.com/industry-analysis/vaccine-storage-packaging-market

Comments

Post a Comment

Popular posts from this blog

Transdermal Drug Delivery System Market Revenue Forecast 2030

Image
  Transdermal Drug Delivery System Market Growth & Trends The global  transdermal drug delivery system market  is expected to reach USD 145.0 billion by 2030, registering a CAGR of 11.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing adoption of transdermal patches, such as in the case of diabetes, which requires sustained and a daily dose of insulin is expected to provide the market with growth opportunities during the forecast period. High demand for pain-free drug delivery is a major driving factor of the transdermal drug delivery systems market. In the case of diabetes, insulin has to be administered into the patient's body with the help of injections on a continuous basis. Continuous usage of injections to deliver insulin causes pain and increases the risk of transmission of chronic diseases, thus, making transdermal patches a better choice for delivering insulin in diabetic patients. Request a free sample copy or view t...
Read more

Liquid Biopsy Market Size, Share & Trends Analysis Report, 2030

Image
  Liquid Biopsy Market Growth & Trends The global  liquid biopsy market  size is expected to reach USD 22.86 billion by 2030, expanding at a CAGR of 12.46% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period. In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expecte...
Read more

Virtual Clinical Trials Market Size Reaches USD 12.9 Billion By 2030

Image
  The global  virtual clinical trials market  size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth. There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology. The market is recovering at a significant pace after the pandemic as ...
Read more